Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Imperial College London, London, United Kingdom.
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.
J Am Coll Cardiol. 2018 Apr 10;71(14):1513-1524. doi: 10.1016/j.jacc.2018.01.066.
Delayed coronary obstruction (DCO) is an uncommon and barely reported complication following transcatheter aortic valve replacement (TAVR).
The aim of this study was to describe the incidence and pathophysiological features of DCO after TAVR, obtained from a large international multicenter registry.
Data were retrospectively collected from an international multicenter registry consisting of 18 centers between November 2005 and December 2016.
During the study period, 38 DCO (incidence 0.22%) cases were identified from a total of 17,092 TAVR procedures. DCO occurred more commonly after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and if self-expandable valves were used during the index procedure (0.36% vs. 0.11% balloon expandable; p < 0.01). DCO was most likely to occur ≤24 h after the TAVR procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 h and ≤7 days, with the remaining 14 (36.8%) at ≥60 days. The most frequent presentation was cardiac arrest (31.6%; n = 12), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was obstructed in most cases (92.1%; n = 35). Percutaneous coronary intervention was attempted in the majority of cases (74.3% left main; 60% right coronary), and stent implantation was successful in 68.8%. The overall in-hospital death rate was 50% (n = 19), and was higher if DCO occurred ≤7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).
DCO following TAVR is a rare phenomenon that is associated with a high in-hospital mortality rate. Clinicians should be aware that coronary obstruction can occur after the original TAVR procedure and have a low threshold for performing coronary angiography when clinically suspected.
延迟性冠状动脉阻塞(DCO)是经导管主动脉瓣置换术(TAVR)后罕见且鲜有报道的并发症。
本研究旨在描述从一个大型国际多中心注册中心获得的 TAVR 后 DCO 的发生率和病理生理特征。
数据从 2005 年 11 月至 2016 年 12 月期间的 18 个中心组成的国际多中心注册中心中回顾性收集。
在研究期间,从总共 17092 例 TAVR 手术中发现了 38 例 DCO(发生率为 0.22%)。在经导管主动脉瓣瓣中瓣(0.89% vs. 0.18%;p<0.001)和如果在指数手术中使用自膨式瓣膜时,DCO 更常见。DCO 最有可能在 TAVR 手术后 24 小时内发生(47.4%;n=18);6 例(15.8%)发生在 24 小时至 7 天之间,其余 14 例(36.8%)发生在 60 天以上。最常见的表现是心脏骤停(31.6%;n=12),其次是 ST 段抬高型心肌梗死(23.7%;n=9)。大多数情况下阻塞的是左冠状动脉(92.1%;n=35)。大多数病例尝试了经皮冠状动脉介入治疗(74.3%为左主干;60%为右冠状动脉),支架植入成功率为 68.8%。总的住院死亡率为 50%(n=19),如果 DCO 发生在指数手术后 7 天内,死亡率更高(62.5% vs. 28.6%;p=0.09)。
TAVR 后 DCO 是一种罕见现象,与较高的住院死亡率相关。临床医生应意识到,在原始 TAVR 手术后可能会发生冠状动脉阻塞,并且当临床怀疑时,应毫不犹豫地进行冠状动脉造影。